Lymphocytic leukemia, chronic, B-cell

Clinical trials for Lymphocytic leukemia, chronic, B-cell explained in plain language.

Never miss a new study

Get alerted when new Lymphocytic leukemia, chronic, B-cell trials appear

Sign up with your email to follow new studies for Lymphocytic leukemia, chronic, B-cell, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New cocktail aims to tackle tough leukemia

Disease control Completed

This phase II study tested a combination of three drugs—ibrutinib, fludarabine, and pembrolizumab—in 15 people with high-risk or relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if the combo could produce a complete r…

Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC, B-CELL

Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC

Lymphocytic leukemia, chronic, B-cell

Get alerted when new Lymphocytic leukemia, chronic, B-cell trials appear

New cocktail aims to tackle tough leukemia